CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Chief Scientific Officer Stephen F. Betz sold $112K of Crinetics Pharmaceuticals, Inc.
Sold$111,780
$37.26Price
3,000Shares
−4%Stake
What CRNX did after the filing
- The stock from Fri, Jan 26 close, $37.18
- +11.8%
- S&P 500, same days
- +4.9%
Measured over 30 trading days, to the Mar 11 close.
Traded Thu, Jan 25. Filed Fri, Jan 26, 12:50 PM ET, during the session. Returns use the Jan 26 close and the Mar 11 close. Not investment advice.